Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126810 · ClinicalTrials.gov registry record
Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
A clinical trial of Li-Fraumeni Syndrome, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05126810: Recruiting study of Li-Fraumeni Syndrome, sponsored by M.D. Anderson Cancer Center.
NCT05126810 is a study of Li-Fraumeni Syndrome that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 500 participants, below the 1,993-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05126810, a study of Li-Fraumeni Syndrome, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic counseling to personalized genetic counseling.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2027-10-02 |
What NCT05126810 shows while recruiting
NCT05126810 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,993-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Li-Fraumeni Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT05126810 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05126810 about?
NCT05126810 is a clinical study titled "Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling". This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic c...
What is the current status of trial NCT05126810?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-11-03. Estimated completion is 2027-10-02.
What conditions does trial NCT05126810 study?
This clinical trial studies the following conditions: Li-Fraumeni Syndrome.
What interventions are being tested in trial NCT05126810?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT05126810?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05126810 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Li-Fraumeni Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
Clinical and Genetic Studies of Li-Fraumeni Syndrome
RECRUITING
-
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
RECRUITING
-
Li-Fraumeni Syndrome/TP53 Biobank
RECRUITING
-
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
ACTIVE NOT RECRUITING · NA
-
Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI